Pini Tsukerman
Company: Nectin Therapeutics Ltd.
Job title: Chief Scientific Officer
Seminars:
Restoring DNAM-1/CD226 Surface Expression with a Potent Anti-PVR mAb, NTX-1088, to Induce Anti-Tumor Immunity 11:30 am
day: Day Two